Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05642871 | DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene | unknown | — | 2 | Qianqian QuOTHER | 0 | Dec 8, 2022 | clinicaltrials |
| NCT05640024 | Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors | unknown | — | 54 | Yonsei UniversityOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05641506 | A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer | unknown | Phase 2 | 50 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05446883 | QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer | unknown | Phase 3 | 498 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05631080 | Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer | unknown | Phase 4 | 50 | Mansoura UniversityOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05622890 | A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer | unknown | Phase 3 | 35 | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 21, 2022 | clinicaltrials |
| NCT05620654 | A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin | unknown | Phase 1 | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 17, 2022 | clinicaltrials |
| NCT03540017 | HIPEC After Initial CRS in Patients Who Have Received NACT | unknown | Phase 1 | 15 | Northwell HealthOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05602831 | Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer | unknown | — | 108 | Fudan UniversityOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05603351 | Prostate Cancer Screening With Abbreviated MRI Protocol(ProstaPilot) | unknown | N/A | 300 | Masaryk Memorial Cancer InstituteOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT04457882 | Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage Tube | unknown | N/A | 112 | Shanghai East HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05025527 | Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study | unknown | N/A | 500 | Shanghai East HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05580341 | Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 | unknown | Phase 3 | 1,200 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05597527 | Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer | unknown | Phase 2 | 35 | Fujian Cancer HospitalOTHER_GOV | 1 | Oct 28, 2022 | clinicaltrials |
| NCT05596851 | Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy. | unknown | — | 15 | European Institute of OncologyOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT03936127 | Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy | unknown | N/A | 360 | Dr. Nicola SchiedaOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT05167175 | The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation | unknown | Phase 2 | 30 | Hongqian GuoOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT05591560 | Itraconazole in Advanced Ovarian Cancer | unknown | N/A | 66 | Tanta UniversityOTHER | 1 | Oct 24, 2022 | clinicaltrials |
| NCT03482089 | Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion(CRADT) | unknown | N/A | 70 | Tongji HospitalOTHER | 1 | Oct 21, 2022 | clinicaltrials |
| NCT04026230 | Impact of Atorvastatin on Prostate Cancer Progression During ADT(ESTO2) | unknown | Phase 3 | 400 | Tampere University HospitalOTHER | 4 | Oct 21, 2022 | clinicaltrials |
| NCT03601143 | Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients(PEARL) | unknown | — | 120 | Technical University of MunichOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05179720 | The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate Biopsy | unknown | N/A | 560 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT05583799 | Efficacy and Adverse Effects of Niraparib in Ovarian Cancer. | unknown | — | 222 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Oct 18, 2022 | clinicaltrials |
| NCT05179707 | A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate Cancer | unknown | — | 936 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05437692 | Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 19 | Shanghai Zhongshan HospitalOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05576519 | Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma | unknown | — | 50 | Sohag UniversityOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05432687 | Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO)(PROSTABDO) | unknown | N/A | 80 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Oct 7, 2022 | clinicaltrials |
| NCT05572099 | ExoDx Prostate Evaluation in Active Surveillance Patient Population | unknown | — | 750 | Exosome Diagnostics, Inc.INDUSTRY | 1 | Oct 7, 2022 | clinicaltrials |
| NCT05570331 | Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women | unknown | — | 2,200 | Ding MaOTHER | 1 | Oct 6, 2022 | clinicaltrials |
| NCT04331535 | The Genomic Medicine at VA Study(GenoVA) | unknown | N/A | 1,076 | Boston VA Research Institute, Inc.OTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT05561413 | Gynaecology Exercise and Mindfulness Study(GEMS) | unknown | N/A | 40 | University of UlsterOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT04239599 | Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate Cancer(RCT-PHART2) | unknown | N/A | 178 | Sunnybrook Health Sciences CentreOTHER | 0 | Sep 29, 2022 | clinicaltrials |
| NCT05560035 | The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery | unknown | N/A | 60 | General Hospital of Ningxia Medical UniversityOTHER | 0 | Sep 29, 2022 | clinicaltrials |
| NCT04245670 | 5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:(5STAR-PC) | unknown | N/A | 75 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT05557565 | A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer | unknown | Phase 2 | 150 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 28, 2022 | clinicaltrials |
| NCT01197625 | Vaccine Therapy in Curative Resected Prostate Cancer Patients | unknown | Phase 1 / Phase 2 | 30 | Oslo University HospitalOTHER | 1 | Sep 27, 2022 | clinicaltrials |
| NCT03278717 | Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients(ICON9) | unknown | Phase 3 | 330 | University College, LondonOTHER | 4 | Sep 27, 2022 | clinicaltrials |
| NCT05537844 | Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma(BriTROC-2) | unknown | — | 250 | Liz-Anne LewsleyOTHER | 1 | Sep 23, 2022 | clinicaltrials |
| NCT05458973 | Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation. | unknown | — | 100 | Yonsei UniversityOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT05532930 | An Exploratory Study of Using Magnetic Resonance Prognostic Imaging Markers for Radiotherapy In Patients With Cervix Cancer (EMPIRIC Study)(EMPIRIC) | unknown | — | 40 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Sep 8, 2022 | clinicaltrials |
| NCT04398446 | Effect of Hemp-CBD on Patients With CIPN(Coala-T-CBD) | unknown | Phase 2 | 56 | Main Line HealthOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT05522907 | Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate Cancer | unknown | — | 1,000 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Aug 31, 2022 | clinicaltrials |
| NCT05523804 | Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer(GO SOAR2) | unknown | — | 800 | NHS GrampianOTHER_GOV | 1 | Aug 31, 2022 | clinicaltrials |
| NCT05512663 | Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer | unknown | N/A | 10 | Jewish General HospitalOTHER | 0 | Aug 23, 2022 | clinicaltrials |
| NCT04015739 | Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse(BOLD) | unknown | Phase 2 | 74 | ARCAGY/ GINECO GROUPOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT05043402 | A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer | unknown | Phase 3 | 400 | OncXerna Theraputics, Inc.INDUSTRY | 0 | Aug 15, 2022 | clinicaltrials |
| NCT03934827 | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour(MICROBIOME) | unknown | Phase 1 | 120 | Imperial College LondonOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT05496517 | Ovarian Cancer Individualized Scoring System Scoring System(OCISS) | unknown | — | 1,000 | Assiut UniversityOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT05285319 | Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer | unknown | Phase 2 | 82 | Cairo UniversityOTHER | 1 | Aug 10, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Dec 8, 2022source: clinicaltrials